Literature DB >> 7619981

Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans.

F A Hameedi1, M I Rosen, E F McCance-Katz, T J McMahon, L H Price, P I Jatlow, S W Woods, T R Kosten.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7619981     DOI： 10.1016/0006-3223(94)00361-6

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  31 in total

Review 1.  Pharmacotherapies for cocaine dependence.

Authors:  G O'Leary; R D Weiss
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

Review 2.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

3.  Disulfiram effects on responses to intravenous cocaine administration.

Authors:  Jennifer R Baker; Peter Jatlow; Elinore F McCance-Katz
Journal:  Drug Alcohol Depend       Date:  2006-09-18       Impact factor: 4.492

Review 4.  [New developments in the pharmacotherapy of cocaine dependence].

Authors:  G Wiesbeck; K Dürsteler-MacFarland
Journal:  Nervenarzt       Date:  2006-09       Impact factor: 1.214

5.  A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence.

Authors:  Helen M Pettinati; Kyle M Kampman; Kevin G Lynch; Hu Xie; Charles Dackis; Amanda R Rabinowitz; Charles P O'Brien
Journal:  Addict Behav       Date:  2007-11-17       Impact factor: 3.913

Review 6.  Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Authors:  Colin N Haile; Thomas R Kosten; Therese A Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

7.  Chronic loss of noradrenergic tone produces β-arrestin2-mediated cocaine hypersensitivity and alters cellular D2 responses in the nucleus accumbens.

Authors:  Meriem Gaval-Cruz; Richard B Goertz; Daniel J Puttick; Dawn E Bowles; Rebecca C Meyer; Randy A Hall; Daijin Ko; Carlos A Paladini; David Weinshenker
Journal:  Addict Biol       Date:  2014-08-13       Impact factor: 4.280

Review 8.  Norepinephrine and stimulant addiction.

Authors:  Mehmet Sofuoglu; R Andrew Sewell
Journal:  Addict Biol       Date:  2008-09-22       Impact factor: 4.280

9.  DBH gene as predictor of response in a cocaine vaccine clinical trial.

Authors:  Thomas R Kosten; Coreen B Domingo; Sara C Hamon; David A Nielsen
Journal:  Neurosci Lett       Date:  2013-02-28       Impact factor: 3.046

10.  Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase.

Authors:  Thomas R Kosten; Guiying Wu; Wen Huang; Mark J Harding; Sara C Hamon; Jaakko Lappalainen; David A Nielsen
Journal:  Biol Psychiatry       Date:  2012-08-18       Impact factor: 13.382
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.